We are live on
!
Find out more
LPC
Lion Point Capital Portfolio holdings
AUM
$16.7M
1-Year Est. Return
119.35%
This Fund
S&P 500
This Quarter
Est. Return
+7.13%
1 Year Est. Return
+119.35%
3 Year Est. Return
+204.43%
5 Year Est. Return
+220.32%
10 Year Est. Return
+1,396.08%
AUM
$454M
AUM Growth
-$425M
(-48%)
Cap. Flow
-$464M
Cap. Flow
% of AUM
-102.31%
Top 10 Holdings %
Top 10 Hldgs %
68.39%
Holding
48
New
8
Increased
7
Reduced
8
Closed
7
Top Buys
| 1 |
Milestone Pharmaceuticals
MIST
|
+$4.62M |
| 2 |
ERF
Enerplus Corporation
ERF
|
+$4.21M |
| 3 |
CIVI
Civitas Resources
CIVI
|
+$3.83M |
| 4 |
Mirum Pharmaceuticals
MIRM
|
+$1.93M |
| 5 |
Chord Energy
CHRD
|
+$1.67M |
Top Sells
| 1 |
SWIR
Sierra Wireless
SWIR
|
+$31.9M |
| 2 |
ReNew
RNW
|
+$10M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$8.88M |
| 4 |
EXE
Expand Energy Corp
EXE
|
+$8.46M |
| 5 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
+$6.86M |
Sector Composition
| 1 | Energy | 21.1% |
| 2 | Healthcare | 13.42% |
| 3 | Financials | 5.85% |
| 4 | Consumer Discretionary | 3.89% |
| 5 | Communication Services | 3.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$782B
| $81.6M | 17.98% |
228,500
| – | – |
|
2
PUT
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.4B
| $46.8M | 10.31% |
375,000
+250,000
| +200% | +$33M |
|
|
3
Chord Energy
CHRD
$6.99B
| $33.6M | 7.4% |
250,500
+13,000
| +5% | +$1.67M |
|
4
PUT
iShares Russell 2000 ETF
IWM
$82.6B
| $30.3M | 6.68% |
183,800
-1,346,200
| -88% | -$246M |
|
5
WisdomTree
WT
$3.08B
| $26.5M | 5.85% |
4,521,979
| – | – |
|
6
PUT
iShares MSCI Emerging Markets ETF
EEM
$28.4B
| $20.9M | 4.61% |
+600,000
| New | +$23.4M |
|
|
EXE
7
Expand Energy Corp
EXE
$21.1B
| $19.4M | 4.27% |
209,250
-90,000
| -30% | -$8.46M |
|
|
MRNS
8
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $19M | 4.18% |
3,684,622
| – | – |
|
|
BFI
9
DELISTED
BurgerFi International, Inc. Common Stock
BFI
| $17.6M | 3.89% |
2,745,938
| – | – |
|
|
OPTU
10
Optimum Communications Inc
OPTU
$348M
| $14.6M | 3.22% |
1,575,000
-425,000
| -21% | -$4.07M |
|
|
CIVI
11
DELISTED
Civitas Resources
CIVI
| $14.2M | 3.13% |
230,000
+65,000
| +39% | +$3.83M |
|
|
CTIC
12
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $11.7M | 2.57% |
4,389,546
-1,100,000
| -20% | -$6.86M |
|
|
13
Milestone Pharmaceuticals
MIST
$154M
| $11.2M | 2.46% |
1,557,233
+608,663
| +64% | +$4.62M |
|
|
ERF
14
DELISTED
Enerplus Corporation
ERF
| $10.3M | 2.27% |
875,000
+300,000
| +52% | +$4.21M |
|
15
CALL
US Foods
USFD
$21.8B
| $9.25M | 2.04% |
+350,000
| New | +$10.9M |
|
|
PDCE
16
DELISTED
PDC Energy, Inc.
PDCE
| $8.96M | 1.98% |
130,398
| – | – |
|
|
TCDA
17
DELISTED
Tricida, Inc. Common Stock
TCDA
| $8.71M | 1.92% |
1,367,597
-459,132
| -25% | -$5.02M |
|
|
ARNC
18
DELISTED
Arconic Corporation
ARNC
| $8.42M | 1.86% |
812,358
-25,000
| -3% | -$649K |
|
|
DRRX
19
DELISTED
DURECT Corp
DRRX
| $7.85M | 1.73% |
1,428,307
+125,523
| +10% | +$765K |
|
20
Insmed
INSM
$23.3B
| $7.63M | 1.68% |
397,169
| – | – |
|
21
Ovintiv
OVV
$15.9B
| $5.44M | 1.2% |
90,000
| – | – |
|
22
Kiniksa Pharmaceuticals
KNSA
$4.7B
| $5.14M | 1.13% |
480,000
| – | – |
|
23
PUT
Apple
AAPL
$4.89T
| $4.84M | 1.07% |
35,000
| – | – |
|
24
Battalion Oil
BATL
$34.6M
| $3.85M | 0.85% |
352,851
| – | – |
|
25
PUT
NVIDIA
NVDA
$5.02T
| $3.64M | 0.8% |
+300,000
| New | +$4.74M |
|
Similar funds
PA
PA
SR
SCTC
SRA
CP
B
CVV
Lion Point Capital's Q3 2022 Portfolio in Review
As of Q3 2022, Lion Point Capital held 48 positions worth $454M, down 48% from $878M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Lion Point Capital withdrew a net $464M in Q3 2022, closing 7 positions and reducing 8 holdings. Its most notable exit was ReNew, an estimated $10M position sold in full.
By sector, the portfolio is most concentrated in Energy at 21% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lion Point Capital opened a new position in Mirum Pharmaceuticals worth $1.72M.
- Lion Point Capital's largest Q3 2022 buy was Mirum Pharmaceuticals: 80,000 shares worth $1.72M.
- Lion Point Capital added most to Milestone Pharmaceuticals in Q3 2022, an estimated $4.62M increase.
- Lion Point Capital's biggest Q3 2022 reduction was Sierra Wireless, cutting an estimated $31.9M.
- Lion Point Capital fully exited ReNew in Q3 2022, selling an estimated $10M.
- Lion Point Capital's ten largest holdings make up 68% of its $454M portfolio in Q3 2022.
- Lion Point Capital opened 8 new positions and closed 7 in Q3 2022.
- Lion Point Capital's portfolio value fell 48% quarter-over-quarter to $454M.
Based on Lion Point Capital's 13F filing for Q3 2022, filed 14 Nov 2022.